Preferred Label : Corticosteroid Cardioprotection Pathway;
NCIt related terms : Corticosteroids and cardioprotection;
Alternative definition : BIOCARTA: Myocardial infarction damages heart tissue both during the initial ischemia
and the subsequent reperfusion of tissues with oxygen. Corticosteroids can protect
cardiac tissue from damage following a heart attack, but the mechanisms by which corticosteroids
are cardioprotective have not been clear and negative side effects such as reduced
wound healing may result from their use. Corticosteroids exert a variety of actions
through binding to the glucocorticoid receptor (GR), a member of the steroid hormone
receptor gene family. GR acts as a ligand-dependent transcription factor, but some
of the cardioprotective effects mediated by GR-bound corticosteroids are non-transcriptional
in nature. Glucocorticoids are commonly used as anti-inflammatory drugs in a variety
of conditions, and some of their effects in the heart result from inhibition of the
inflammatory response of heart tissue to ischemia and reperfusion. NF-kB is a transcription
factor involved in signaling by inflammatory factors such as TNF, and is repressed
by glucocorticoids. Annexin-1 is a calcium-dependent phospholipid binding protein
whose expression is induced by corticosteroids and inhibits the infiltration of neutrophils
into tissue, blocking reperfusion-induced inflammatory heart damage. A non-transcriptional
cardioprotective effect of glucocorticoids is activation of NO production by endothelial
nitric oxide synthase (eNOS). Glucocorticoids activate eNOS through activation of
PI3 kinase and AKT and increased NO produced by eNOS can diffuse into surrounding
tissues to prevent clotting and cause vasodilation. The beta-2 adrenergic receptor
can also activate PI3 kinase and may synergize with glucocorticoids in this pathway.
The atrial natriuretic factor (ANF) is a peptide secreted by the atrial wall in response
to increased atrial pressure such as occurs during cardiac failure and to be decreased
by myocardial infarction. Glucocorticoids increase the secretion of ANF by acting
at the transcriptional level to increase expression of the pro-ANF peptide, perhaps
inducing increased water excretion in the kidneys to reduce blood volume and reduce
atrial pressure. The exploration of glucocorticoid responses may allow the identification
of compounds that retain the cardioprotective activities but do not inhibit wound
healing. Alternative mechanisms of eNOS activation may also provide a route to identify
cardioprotective drugs. (This definition may be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_gcrPathway;
Origin ID : C39091;
UMLS CUI : C1511530;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element